MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejim.2026.106889

Медицинская библиотека · European journal of internal medicine · 2026

Venous thromboembolism risk assessment in hospital-at-home setting: A prospective cohort study (the TROMBODOM study).

Modesto Dos Santos Joao, Les Bujanda Iñigo, Etayo-Urtasun Paula, Sánchez Álvarez Julio, Izquierdo Mikel, Sáez De Asteasu Mikel L, Ruiz Castellano María, Llorente Diez Begoña, Salinas Urra Silvia, Pulido Fontes Marta, Lecumberri Ramón

Сравнительное исследованиеСтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Venous thromboembolism (VTE) is a significant cause of preventable mortality in hospitalized patients. While risk assessment models such as Padua and IMPROVE-VTE scores have been validated in conventional hospitalization (CH), their applicability to hospital-at-home (HaH) remains uncertain.

OBJECTIVES

To evaluate thrombotic risk stratification in HaH by comparing the 90-day VTE incidence and mortality between HaH and CH and developing an HaH-specific VTE predictive model.

METHODS

This prospective observational cohort study comprised 2062 patients (1689 HaH; 373 CH) admitted for acute medical illnesses between 2022 and 2024. Thrombotic risk was assessed using Padua and IMPROVE-VTE scores. Primary outcomes were 90-day VTE incidence and mortality. Predictors of VTE in HaH were identified using multivariable logistic regression and incorporated into a novel model (TROMBODOM).

RESULTS

HaH patients were older (mean, 71.7 vs. 64.5 years, respectively) and more often admitted for infections (90.1% vs. 63.0%, respectively) and cardiorespiratory failure (36.6% vs. 25.7%, respectively). A larger proportion of patients in HaH were classified as high-risk based on Padua (75.1% vs. 52.0%, respectively) and IMPROVE-VTE (46.3% vs. 27.1%, respectively). Ninety-day VTE incidence was lower in HaH (1.2% vs. 3.5%, respectively; OR, 0.33; 95%CI, 0.16-0.67), whereas mortality was higher (15.8% vs. 9.9%, respectively; OR: 1.70, 95%CI: 1.18-2.44). Padua and IMPROVE-VTE scores showed modest discriminatory capacity (AUC: 0.65 and 0.75, respectively) in HaH. TROMBODOM achieved superior predictive performance (AUC: 0.86).

CONCLUSIONS

Padua and IMPROVE-VTE overestimated the thrombotic risk of HaH. The newly developed TROMBODOM model improved VTE risk stratification in HaH and requires external validation.

Для цитирования: Modesto Dos Santos Joao, Les Bujanda Iñigo, Etayo-Urtasun Paula, Sánchez Álvarez Julio, Izquierdo Mikel, Sáez De Asteasu Mikel L, Ruiz Castellano María, Llorente Diez Begoña, Salinas Urra Silvia, Pulido Fontes Marta, Lecumberri Ramón. Venous thromboembolism risk assessment in hospital-at-home setting: A prospective cohort study (the TROMBODOM study).. European journal of internal medicine. 2026. DOI: 10.1016/j.ejim.2026.106889.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.